Coronavirus

Stanford creates virtual scientist to accelerate drug and vaccine discovery

Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.

How can hemp compounds block the COVID-19 virus infection?

Research demonstrates the ability to prevent COVID-19 from entering human cells through cannabinoid acids binding to a SARS-CoV-2 protein, blocking infection from the virus.

Universal COVID vaccines can learn from the common cold

Research shows that T cells, created by the common cold, can give some protection against COVID - which means that universal vaccines can mimic this technology.

COVID vaccine can cause temporary change to menstruation cycle

Scientists analysed 23,754 menstrual cycles to find that menstruation can be temporarily, harmlessly changed - by taking two mRNA vaccines during the same cycle.

More trusting societies have greater success managing COVID-19

Research has found that countries with higher success in minimising coronavirus cases and deaths, have more trust within their society and governments.

‘Levelling-up’: The emerging role of education technology

Al Kingsley, CEO at NetSupport, discusses the potential role of education technology in "levelling up" - especially for vulnerable communities.

True disruption in education: An opportune moment for lasting change?

Christel Wolthoorn, Managing Director of LovedBy Design, examines how the education sector dealt with COVID disruption and the work that remains.

Study shows fourth booster dose increases antibodies fivefold

In Israel, healthcare professionals and those over 60 are now being encouraged to take the fourth booster dose - which appears to significantly increase waning third dose antibodies.

Study finds young COVID patients have increased oxidative stress

According to new data, even young COVID patients have increased oxidative stress - a factor connected to ageing, diabetes and HIV.

Shark antibody-like proteins could neutralise COVID-19 viruses

Antibody-like proteins from the immune systems of sharks could help to prepare for future coronaviruses, according to new research.

Convidecia vaccine 57.5% effective against symptomatic COVID

Phase Three trial shows Convidecia vaccine 57.5% effective against symptomatic COVID, while 91.7% effective against severe COVID.

Study identifies factors in blood linked to severe COVID

Unique “indicators” in the blood of patients with severe and fatal COVID could create simple diagnostic tests - to help doctors identify who could become critically ill.

European Commission approves Novavax COVID vaccine for use

The Commission gave a conditional marketing authorisation (CMA) to the Novavax COVID vaccine, with 100 million doses expected in early 2022.

Scientists say AstraZeneca protection decreases after three months

According to data from two million people in Scotland and 42 million people in Brazil, AstraZeneca vaccine protection drops significantly three months after double-dosing.

Study says prior infection gives 19% protection against Omicron

COVID infection previously created 85% protection against Delta - now, scientists say that this protection falls to 19% against Omicron.

What are the side effects of the Moderna booster vaccine?

Here, we explain side effects of the Moderna booster vaccine - while taking a look at the Omicron variant.

Long COVID: A global problem needing a global solution

Professor Amitava Banerjee turns our thoughts towards Long COVID, a global problem needing a global solution.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders